MYM Signs MOU With Colombian Medical Cannabis Company

MYM signes MOU with Columbian cultivator

CANADA: MYM Nutraceuticals has signed a Memorandum of Understanding (MOU) with NEWCANNA, a leading Colombian medical cannabis company. MYM and NEWCANNA are proposing to form a new, jointly-owned company in Colombia to focus on the large-scale commercial cultivation and transformation of cannabis and hemp for medical, scientific and industrial purposes, and export to worldwide markets. NEWCANNA has agreements in Read the full article…

The Nutraceuticals Market Is Expected To Grow To $275 Billion By 2021

KPMG forecast that the nutraceuticals market will be worth around $250 billion by 2018, and while the exact scope of what is considered a nutraceutical is broad and variable, the products identified in the KPMG report largely fell within the GBI definition of nutraceuticals.

UNITED KINGDOM:  Humans have been consuming choice foods for their medical benefits for millennia. The ancient Egyptians had over 800 known pharmacological treatments for disease, of which 160 were plant products – including compounds being investigated for use in disease today, such as cannabis Historically, herbal medicine utilized many compounds that are now considered nutraceuticals. For Read the full article…